I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 6 studies | 23% ± 5% | |
| endothelial cell | 3 studies | 26% ± 4% | |
| glial cell | 3 studies | 22% ± 2% | |
| myeloid cell | 3 studies | 22% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 6 studies | 23% ± 5% | |
| endothelial cell | 3 studies | 26% ± 4% | |
| glial cell | 3 studies | 22% ± 2% | |
| myeloid cell | 3 studies | 22% ± 6% |
Insufficient scRNA-seq data for expression of GAS2L3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 99% | 562.10 | 1799 / 1809 | 96% | 21.99 | 454 / 472 |
| intestine | 100% | 451.98 | 962 / 966 | 94% | 7.58 | 493 / 527 |
| esophagus | 98% | 287.87 | 1422 / 1445 | 93% | 7.90 | 171 / 183 |
| lung | 100% | 522.49 | 576 / 578 | 82% | 4.21 | 951 / 1155 |
| stomach | 88% | 220.57 | 315 / 359 | 92% | 7.20 | 264 / 286 |
| breast | 95% | 212.80 | 435 / 459 | 85% | 4.87 | 946 / 1118 |
| bladder | 100% | 224.81 | 21 / 21 | 79% | 5.14 | 397 / 504 |
| kidney | 94% | 303.03 | 84 / 89 | 83% | 14.94 | 748 / 901 |
| ovary | 91% | 143.69 | 163 / 180 | 81% | 3.90 | 348 / 430 |
| uterus | 55% | 73.00 | 94 / 170 | 89% | 6.39 | 410 / 459 |
| adrenal gland | 79% | 121.26 | 204 / 258 | 38% | 3.13 | 88 / 230 |
| pancreas | 39% | 50.19 | 129 / 328 | 75% | 3.71 | 134 / 178 |
| liver | 69% | 99.23 | 157 / 226 | 44% | 2.68 | 178 / 406 |
| adipose | 99% | 315.11 | 1195 / 1204 | 0% | 0 | 0 / 0 |
| thymus | 86% | 123.39 | 563 / 653 | 11% | 0.32 | 67 / 605 |
| prostate | 89% | 203.04 | 219 / 245 | 8% | 0.26 | 39 / 502 |
| spleen | 89% | 151.68 | 215 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 89% | 6.20 | 40 / 45 |
| blood vessel | 72% | 178.48 | 966 / 1335 | 0% | 0 | 0 / 0 |
| heart | 67% | 118.12 | 579 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 55% | 3.54 | 44 / 80 |
| brain | 11% | 15.94 | 279 / 2642 | 41% | 3.32 | 289 / 705 |
| peripheral blood | 30% | 129.05 | 278 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 24% | 0.74 | 7 / 29 |
| muscle | 13% | 13.64 | 103 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030036 | Biological process | actin cytoskeleton organization |
| GO_0051764 | Biological process | actin crosslink formation |
| GO_0000226 | Biological process | microtubule cytoskeleton organization |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0015630 | Cellular component | microtubule cytoskeleton |
| GO_0005884 | Cellular component | actin filament |
| GO_0005874 | Cellular component | microtubule |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0008017 | Molecular function | microtubule binding |
| GO_0008093 | Molecular function | cytoskeletal anchor activity |
| GO_0051015 | Molecular function | actin filament binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003779 | Molecular function | actin binding |
| Gene name | GAS2L3 |
| Protein name | Growth arrest specific 2 like 3 GAS2-like protein 3 (Growth arrest-specific protein 2-like 3) Growth arrest specific 2 like 3 (Growth arrest-specific 2 like 3, isoform CRA_c) |
| Synonyms | hCG_21805 |
| Description | FUNCTION: Cytoskeletal linker protein. May promote and stabilize the formation of the actin and microtubule network. . |
| Accessions | ENST00000537247.5 H0YIT6 ENST00000550295.1 ENST00000539410.2 ENST00000266754.9 F8VSB7 Q86XJ1 ENST00000552854.1 ENST00000547754.6 G3V1N3 |
